LEUKEMIA, ACUTE LYMPHOBLASTIC
Clinical trials for LEUKEMIA, ACUTE LYMPHOBLASTIC explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, ACUTE LYMPHOBLASTIC trials appear
Sign up with your email to follow new studies for LEUKEMIA, ACUTE LYMPHOBLASTIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy blinatumomab shows promise in kids with relapsed leukemia
Disease control CompletedThis Phase 3 trial tested the drug blinatumomab in 111 children with high-risk relapsed B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is an immunotherapy that helps the body's immune cells attack cancer cells. The study compared blinatumomab to standard chemotherap…
Matched conditions: LEUKEMIA, ACUTE LYMPHOBLASTIC
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Researchers review CAR T-Cell results in kids with B-ALL
Knowledge-focused CompletedThis study looked back at the medical records of 57 children and young adults (under 25) who received CAR T-cell therapy for B-cell acute lymphoblastic leukemia (B-ALL). The goal was to understand how well the treatment worked and what side effects occurred, especially in those w…
Matched conditions: LEUKEMIA, ACUTE LYMPHOBLASTIC
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC